LYEL compared with SPTX: revenue, margins and what each company keeps, and the suppliers and customers both name

LYELLyell Immunopharma, Inc.

Mkt capRevenueRevenue

SPTXSeaport Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

LYELLyell Immunopharma, Inc.

SPTXSeaport Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only LYEL 11

—City of Hope Comprehensive Cancer Centerunlistedsupplier

—Dana Farber Cancer Instituteunlistedsupplier

—Innovative Cellular Therapeutics Holdings Limited and Innovative Cellular Therapeutics, Inc. (together, ICT)unlistedsupplier

—Miltenyi CliniMACS PRODIGY ®unlistedsupplier

7 more · LYEL chain ›

Shared 0

No disclosed counterparties: SPTX.

Only SPTX 0

None

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

LYELLyell Immunopharma, Inc.

11.06▲+1.65%

Mkt cap$266.6MRevenue$4,000Q2 FY26Revenue$36,000FY25

SPTXSeaport Therapeutics, Inc.

20.20▲+0.94%

Regular sessionNov 3 '26

Mkt cap$1.1BRevenue—Revenue—

Compare

Regular sessionNov 3 '26

LYELLyell Immunopharma, Inc.

SPTXSeaport Therapeutics, Inc.

11.06▲+1.65%

Price

20.20▲+0.94%

$266.6M

Mkt cap

$1.1B

Q2 FY26$4,000

Revenue

—

FY25$36,000

Revenue

—

LYEL11.06▲+1.65%vsSPTX20.20▲+0.94%Regular sessionNov 3 '26